Lexeo Therapeutics, Inc. (LXEO)
2.79
-0.12
(-3.96%)
USD |
NASDAQ |
Nov 06, 10:24
Lexeo Therapeutics Market Cap : 219.36M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 228.40M |
| November 04, 2026 | 253.95M |
| November 03, 2026 | 244.52M |
| November 02, 2026 | 240.59M |
| October 30, 2026 | 246.88M |
| October 29, 2026 | 240.59M |
| October 28, 2026 | 246.09M |
| October 27, 2026 | 225.65M |
| October 26, 2026 | 212.28M |
| October 23, 2026 | 220.14M |
| October 22, 2026 | 227.22M |
| October 21, 2026 | 235.87M |
| October 20, 2026 | 237.44M |
| October 19, 2026 | 217.00M |
| October 16, 2026 | 207.56M |
| October 15, 2026 | 217.00M |
| October 14, 2026 | 206.78M |
| October 13, 2026 | 215.43M |
| October 12, 2026 | 239.01M |
| October 09, 2026 | 253.95M |
| October 08, 2026 | 252.38M |
| October 07, 2026 | 260.24M |
| October 06, 2026 | 259.45M |
| October 05, 2026 | 268.10M |
| October 02, 2026 | 277.54M |
| Date | Value |
|---|---|
| October 01, 2026 | 284.61M |
| September 30, 2026 | 265.74M |
| September 29, 2026 | 268.89M |
| September 28, 2026 | 246.88M |
| September 25, 2026 | 260.24M |
| September 24, 2026 | 266.53M |
| September 23, 2026 | 276.75M |
| September 22, 2026 | 319.99M |
| September 21, 2026 | 320.78M |
| September 18, 2026 | 330.21M |
| September 17, 2026 | 328.64M |
| September 16, 2026 | 327.07M |
| September 15, 2026 | 324.71M |
| September 14, 2026 | 331.00M |
| September 11, 2026 | 334.15M |
| September 10, 2026 | 342.79M |
| September 09, 2026 | 352.23M |
| September 08, 2026 | 374.24M |
| September 04, 2026 | 384.46M |
| September 03, 2026 | 380.53M |
| September 02, 2026 | 375.82M |
| September 01, 2026 | 369.53M |
| August 31, 2026 | 374.24M |
| August 28, 2026 | 382.11M |
| August 27, 2026 | 392.33M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.180B |
| Oncolytics Biotech, Inc. | 56.65M |
| Sangamo Therapeutics, Inc. | 47.23M |
| Sarepta Therapeutics, Inc. | 1.874B |
| Anixa Biosciences, Inc. | 104.45M |
Market Cap Related Metrics
| Price to Book Value | 0.9332 |
| Price | 2.79 |
| Earnings Yield | -41.49% |